FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kazimierz Wisniewski

Research Profile

Chemicals & Drugs

Concepts & Ideas

Drug Dose Response Relationship

Living Beings

Rats

Anatomy

Physiology

Postural Balance

Procedures

Radioligand Assay

Co-author Network

Publications

TOP 3
Sebastian Rehberg; PJ Rivière; Claudio D Schteingart; Perenlei Enkhbaatar; Nicky Ferdyan; Erin La; Régent Laporte; Steve Qi; Janina Rehberg; Lillian D Traber; Kazimierz Wisniewski; Daniel L Traber
Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor.
Kazimierz Wisniewski; Hiroe Tariga; Halina Wisniewska; Sudar Alagarsamy; Glenn Croston; Robert Galyean; Joshua Heitzmann; Arash Kohan; Régent Laporte; PJ Rivière; Claudio D Schteingart
New, potent, selective, and short-acting peptidic V1a receptor agonists.
Todd W Vanderah; Tally Largent-Milnes; Josephine Lai; Frank Porreca; Richard A Houghten; Frédérique Menzaghi; Kazimierz Wisniewski; Jacek Stalewski; Javier Sueiras-Diaz; Robert Galyean; Claudio D Schteingart; Jean-Louis Junien; Jerzy Trojnar; PJ Rivière
Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kazimierz Wisniewski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sebastian Rehberg; PJ Rivière; Claudio D Schteingart; Perenlei Enkhbaatar; Nicky Ferdyan; Erin La; Régent Laporte; Steve Qi; Janina Rehberg; Lillian D Traber; Kazimierz Wisniewski; Daniel L Traber
Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor.
Critical care medicine 2012;40(6):1957-60.
2011: Kazimierz Wisniewski; Hiroe Tariga; Halina Wisniewska; Sudar Alagarsamy; Glenn Croston; Robert Galyean; Joshua Heitzmann; Arash Kohan; Régent Laporte; PJ Rivière; Claudio D Schteingart
New, potent, selective, and short-acting peptidic V1a receptor agonists.
Journal of medicinal chemistry 2011;54(13):4388-98.
2008: Todd W Vanderah; Tally Largent-Milnes; Josephine Lai; Frank Porreca; Richard A Houghten; Frédérique Menzaghi; Kazimierz Wisniewski; Jacek Stalewski; Javier Sueiras-Diaz; Robert Galyean; Claudio D Schteingart; Jean-Louis Junien; Jerzy Trojnar; PJ Rivière
Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
European journal of pharmacology 2008;583(1):62-72.
2004: Miriam Andrés; Ana Peña; Sylvain Derick; Danielle Raufaste; Jerzy Trojnar; Kazimierz Wisniewski; Miguel Trueba; Claudine Serradeil-Le Gal; Gilles Guillon
Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms.
European journal of pharmacology 2004;501(1-3):59-69.
2003: Magdalena J Slusarz; Rafal Slusarz; Rajmund Kaźmierkiewicz; Jerzy Trojnar; Kazimierz Wisniewski; Jerzy Ciarkowski
Molecular modeling of the neurohypophyseal receptor/atosiban complexes.
Protein and peptide letters 2003;10(3):295-302.